公司資料
Biotricity 股價、新聞與催化劑
- 股票代碼:
- BTCY
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.06 USD (-12.02%)
收盤價
最後更新: 2026年10月1日
—
市值
股價為何變動
截至 2026年10月1日，BTCY 下跌 12.0%，收於 $0.0587。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Remote Cardiac Monitoring Company
Biotricity develops connected devices and software for cardiac diagnostics and chronic-care monitoring. Its platform links wearable sensors, cloud analytics, certified monitoring centers, and physician workflows.
Bioflux Mobile Cardiac Telemetry
Bioflux is a mobile cardiac telemetry system used to monitor patients for arrhythmias over extended periods. Data are transmitted to a monitoring center so clinically significant events can be reviewed and communicated to healthcare providers.
Biotres Extended Holter
Biotres is a wearable Holter device designed for multi-day recording and analysis. It broadens the company's diagnostic portfolio for physicians who need continuous rhythm data without full real-time telemetry.
Recurring Monitoring Economics
Biotricity generates revenue from devices, software, monitoring services, and reimbursable diagnostic tests. Growth depends on expanding the installed physician base and increasing the number of monitored patients per practice.
Consumer and Chronic-Care Products
Bioheart and related applications extend the technology into personal heart monitoring and longer-term disease management. The company is building a connected ecosystem that can support both prescribed diagnostics and ongoing patient engagement.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。